A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus

Trial Profile

A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2017

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Dec 2017 According to a AntriaBio media release, AntriaBio changed its name to Rezolute.
    • 10 Dec 2015 According to a media release, AntriaBio will use the proceeds from a private placement transaction for phase I trials of AB101 in patients with type 1 and type 2 diabetes.
    • 19 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top